Rituximab is useful in cases of RA where TNF inhibitors are not effective; it depletes the B cells responsible for inflammation and the production of abnormal antibodies and improves the complications of RA (vasculitis and cryoglobulinemia) [108]. This evidence concerns the gene TNF and rheumatoid arthritis.